Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013 (2013), Article ID 429207, 8 pages
http://dx.doi.org/10.1155/2013/429207
Research Article

Metformin Inhibits Expression and Secretion of PEDF in Adipocyte and Hepatocyte via Promoting AMPK Phosphorylation

Department of Endocrinology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Street, Chongqing 400016, China

Received 18 June 2013; Revised 7 August 2013; Accepted 9 September 2013

Academic Editor: Magdalena Klink

Copyright © 2013 Shumin Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Miller and M. J. Birnbaum, “An energetic tale of AMPK-independent effects of metformin,” Journal of Clinical Investigation, vol. 120, no. 7, pp. 2267–2270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Viollet, B. Guigas, N. Sanz Garcia, J. Leclerc, M. Foretz, and F. Andreelli, “Cellular and molecular mechanisms of metformin: an overview,” Clinical Science, vol. 122, no. 6, pp. 253–270, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Zang, A. Zuccollo, X. Hou et al., “AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells,” The Journal of Biological Chemistry, vol. 279, no. 46, pp. 47898–47905, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Bertrand, A. Ginion, C. Beauloye et al., “AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 291, no. 1, pp. H239–H250, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. N. Adamia, D. Virsaladze, N. Charkviani, M. Skhirtladze, and M. Khutsishvili, “Effect of metformin therapy on plasma adiponectin and leptin levels in obese and insulin resistant postmenopausal females with type 2 diabetes,” Georgian Medical News, no. 145, pp. 52–55, 2007. View at Google Scholar · View at Scopus
  6. C. J. Glueck, R. N. Fontaine, P. Wang et al., “Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30,” Metabolism, vol. 50, no. 7, pp. 856–861, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Crowe, L. E. Wu, C. Economou et al., “Pigment epithelium-derived factor contributes to insulin resistance in obesity,” Cell Metabolism, vol. 10, no. 1, pp. 40–47, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Famulla, D. Lamers, S. Hartwig et al., “Pigment epithelium-derived factor (PEDF) is one of the most abundant proteins secreted by human adipocytes and induces insulin resistance and inflammatory signaling in muscle and fat cells,” International Journal of Obesity, vol. 35, no. 6, pp. 762–772, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. L. Borg, Z. B. Andrews, E. J. Duh, R. Zechner, P. J. Meikle, and M. J. Watt, “Pigment epithelium-derived factor regulates lipid metabolism via adipose triglyceride lipase,” Diabetes, vol. 60, no. 5, pp. 1458–1466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Nakamura, S. Yamagishi, H. Adachi, T. Matsui, Y. Kurita, and T. Imaizumi, “Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension,” International Journal of Cardiology, vol. 143, no. 1, pp. 96–98, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Yang, Q. Li, L. Zhong et al., “Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 3, pp. 831–836, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Bell, “Pigment epithelium-derived factor: a not so sympathetic regulator of insulin resistance?” Exercise and Sport Sciences Reviews, vol. 39, no. 4, pp. 187–190, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Filleur, T. Nelius, W. de Riese, and R. C. Kennedy, “Characterization of pedf: a multi-functional serpin family protein,” Journal of Cellular Biochemistry, vol. 106, no. 5, pp. 769–775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. K. Gattu, A. L. Birkenfeld, F. Jornayvaz et al., “Insulin resistance is associated with elevated serum pigment epithelium-derived factor (PEDF) levels in morbidly obese patients,” Acta Diabetologica, vol. 49, supplement 1, pp. S161–S169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Wang, J. J. Wang, J. Li et al., “Pigment epithelium-derived factor suppresses adipogenesis via inhibition of the MAPK/ERK pathway in 3T3-L1 preadipocytes,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 297, no. 6, pp. E1378–E1387, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. M. J. Thomson, M. G. Williams, and S. C. Frost, “Development of insulin resistance in 3T3-L1 adipocytes,” The Journal of Biological Chemistry, vol. 272, no. 12, pp. 7759–7764, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Arsenis and J. N. Livingston, “Alterations in the tyrosine kinase activity of the insulin receptor produced by in vitro hyperinsulinemia,” The Journal of Biological Chemistry, vol. 261, no. 1, pp. 147–153, 1986. View at Google Scholar · View at Scopus
  18. B. Kim, L. L. McLean, S. S. Philip, and E. L. Feldman, “Hyperinsulinemia induces insulin resistance in dorsal root ganglion neurons,” Endocrinology, vol. 152, no. 10, pp. 3638–3647, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Wang, M. L. Xu, S. K. Rasmussen, and M. H. Wang, “Vomifoliol 9-O-α-arabinofuranosyl (1→6)-β-D-glucopyranoside from the leaves of Diospyros Kaki stimulates the glucose uptake in HepG2 and 3T3-L1 cells,” Carbohydrate Research, vol. 346, no. 10, pp. 1212–1216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. T. Lanner, A. Katz, P. Tavi et al., “The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle,” Diabetes, vol. 55, no. 7, pp. 2077–2083, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. T. T. Tran, N. Gupta, T. Goh et al., “Direct measure of insulin sensitivity with the hyperinsulinemic-euglycemic clamp and surrogate measures of insulin sensitivity with the oral glucose tolerance test: correlations with aberrant crypt foci promotion in rats,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 1, pp. 47–56, 2003. View at Google Scholar · View at Scopus
  22. M. E. Griffin, M. J. Marcucci, G. W. Cline et al., “Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade,” Diabetes, vol. 48, no. 6, pp. 1270–1274, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. G. M. Reaven, “Role of insulin resistance in human disease,” Diabetes, vol. 37, no. 12, pp. 1595–1607, 1988. View at Google Scholar · View at Scopus
  24. B. E. Corkey, “Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes?” Diabetes Care, vol. 35, no. 12, pp. 2432–2437, 2012. View at Publisher · View at Google Scholar
  25. M. H. Shanik, Y. Xu, J. Skrha, R. Dankner, Y. Zick, and J. Roth, “Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?” Diabetes Care, vol. 31, supplement 2, pp. S262–268, 2008. View at Google Scholar · View at Scopus
  26. W. J. Pories and G. L. Dohm, “Diabetes: have we got it all wrong? Hyperinsulinism as the culprit: surgery provides the evidence,” Diabetes Care, vol. 35, no. 12, pp. 2438–2442, 2012. View at Publisher · View at Google Scholar
  27. H. Y. Liu, S. Y. Cao, T. Hong, J. Han, Z. Liu, and W. Cao, “Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM),” The Journal of Biological Chemistry, vol. 284, no. 40, pp. 27090–27100, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. J. R. Flores-Riveros, J. C. McLenithan, O. Ezaki, and M. D. Lane, “Insulin down-regulates expression of the insulin-responsive glucose transporter (GLUT4) gene: effects on transcription and mRNA turnover,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 2, pp. 512–516, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Akin, D. Y. Aksoy, N. Cinar et al., “Pigment epithelium-derived factor increases in type 2 diabetes after treatment with metformin,” Clinical Endocrinology, vol. 77, no. 6, pp. 852–856, 2012. View at Publisher · View at Google Scholar